1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Brain Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MF; Ding, WL; Gu, HY; Hu, JJ; Liu, WC | 1 |
Feuerstein, GZ | 1 |
Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y | 1 |
Endo, S; Hirashima, Y; Takaba, M; Takaku, A | 1 |
Bazan, NG; Doucet, JP | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Disorders
Article | Year |
---|---|
Platelet-activating factor: a case for its role in CNS function and brain injury.
Topics: Animals; Brain; Brain Diseases; Humans; Platelet Activating Factor | 1996 |
Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.
Topics: Animals; Brain; Brain Diseases; Brain Ischemia; Cell Membrane; Fatty Acids, Unsaturated; Humans; Membrane Lipids; Nervous System Diseases; Neurons; Oncogenes; Phospholipids; Platelet Activating Factor; Second Messenger Systems; Seizures; Signal Transduction; Synapses; Synaptic Transmission | 1992 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Disorders
Article | Year |
---|---|
Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist.
Topics: Animals; Behavior, Animal; Brain Diseases; Fibrinolytic Agents; Ginkgolides; Hippocampus; Immunohistochemistry; Inflammation; Lactones; Lipopolysaccharides; Maze Learning; Microglia; Microscopy, Electron, Transmission; Neurons; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2007 |
Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS.
Topics: Animals; Brain; Brain Diseases; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor; Retroviridae Infections; Tumor Necrosis Factor-alpha; Tumor Virus Infections | 1997 |
Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment.
Topics: Anti-Inflammatory Agents; Biomarkers; Brain Diseases; Cardiac Surgical Procedures; Drainage; Female; Humans; Infant; Intracranial Pressure; Methylprednisolone; Methylprednisolone Acetate; Platelet Activating Factor; Postoperative Complications; Subdural Effusion; Tomography, X-Ray Computed | 1998 |